Will India need inactivated poliovirus vaccine (IPV) to complete polio eradication?

被引：0
|
作者：
John, TJ [1 ]
机构：
[1] IJMR, Vellore 632002, Tamil Nadu, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2005年 / 122卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：365 / 367
页数：3
相关论文
共 50 条
  • [21] USE OF INACTIVATED OR ORAL POLIOVIRUS VACCINE IN INDIA
    SEHGAL, R
    LANCET, 1991, 338 (8772): : 945 - 945
  • [22] USE OF INACTIVATED OR ORAL POLIOVIRUS VACCINE IN INDIA
    KAUL, R
    LANCET, 1991, 338 (8768): : 702 - 702
  • [23] Importance of experiments in poliovirus-susceptible transgenic mice for evaluating current potency tests of inactivated polio vaccine (IPV)
    Taffs, R
    Dragunsky, E
    Nomura, T
    Hioki, K
    Levenbook, I
    Fitzgerald, E
    REPLACEMENT, REDUCTION AND REFINEMENT OF ANIMAL EXPERIMENTS IN THE DEVELOPMENT AND CONTROL OF BIOLOGICAL PRODUCTS, 1996, 86 : 345 - 345
  • [24] COMBINED IMMUNIZATION PROGRAM OF ORAL POLIO VACCINE (OPV) AND INACTIVATED POLIO VACCINE (IPV) IN THE WEST BANK
    GERICHTER, CB
    HANDSHER, R
    SEVER, I
    GOLDBLUM, N
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1984, 20 (05): : 481 - 481
  • [25] Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region
    Tevi-Benissan, Carol
    Okeibunor, Joseph
    du Chatellier, Gael Maufras
    Assefa, Afework
    Biey, Joseph Nsiari-Muzenyi
    Cheikh, Dah
    Eshetu, Messeret
    Anya, Blanche-Philomene
    Dao, Halima
    Nasir, Yusuf
    Akanmori, Bartholomew Dicky
    Mihigo, Richard
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 : S66 - S75
  • [26] Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014
    Liu, Yan
    Wang, Jun
    Liu, Shijun
    Du, Jian
    Wang, Liang
    Gu, Wenwen
    Xu, Yuyang
    Zuo, Shuyan
    Xu, Erping
    An, Zhijie
    VACCINE, 2017, 35 (09) : 1281 - 1286
  • [27] Polio endgame management: focusing on performance with or without inactivated poliovirus vaccine
    Thompson, Kimberly M.
    LANCET, 2014, 384 (9953): : 1480 - 1482
  • [28] Wild and vaccine-derived poliovirus circulation, and implications for polio eradication
    Lopalco, P. L.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (03): : 413 - 419
  • [29] Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV
    Bakker, Wilfried A. M.
    Thomassen, Yvonne E.
    van't Oever, Aart G.
    Westdijk, Janny
    van Oijen, Monique G. C. T.
    Sundermann, Lars C.
    van't Veld, Peter
    Sleeman, Eelco
    van Nimwegen, Fred W.
    Hamidi, Ahd
    Kersten, Gideon F. A.
    van den Heuvel, Nico
    Hendriks, Jan T.
    van der Pol, Leo A.
    VACCINE, 2011, 29 (41) : 7188 - 7196
  • [30] Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV)
    Rezapkin, G
    Dragunsky, E
    Chumakov, K
    BIOLOGICALS, 2005, 33 (01) : 17 - 27
12345